Thermal Ablation Followed by Immunotherapy for HCC
Clinical trial NCT03864211 · UNKNOWN
Trial details
- NCT number
- NCT03864211
- Sponsor
- Xiangya Hospital of Central South University
- Status
- UNKNOWN
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2019-06-15
- Primary completion
- 2023-05-30
- Enrollment
- 145
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.